Attend Q1 Productions Life Science Regulatory Intelligence Conference

January 14, 2022 09:15:00

Event Highlights:

  • Perspectives of payers on diagnostic evidence and access
  • Evidence targets for increasing coverage through laboratory benefit management
  • Defining diagnostic value relative to costs for payer networks: generating and applying clinical evidence
  • Increased need for prior authorizations has an impact.
  • Impact of changing health policies on test coverage and reimbursement

Q1 Life Science Regulatory Intelligence Conference brings together specialists from around the world in the fields of global intelligence, strategy, policy, and law to share best practices on regulatory concerns. 

Examine how your peers inform internal stakeholders about regulatory changes and competitive intelligence, provide feedback on submissions, and comment on…

Read More>>

For more information, please visit https://ibn.fm/qWIXU

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.